1. Home
  2. ENTA vs PDLB Comparison

ENTA vs PDLB Comparison

Compare ENTA & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.71

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$16.87

Market Cap

393.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
PDLB
Founded
1995
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
393.1M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
ENTA
PDLB
Price
$14.71
$16.87
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$20.40
N/A
AVG Volume (30 Days)
288.3K
67.0K
Earning Date
11-17-2025
01-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
142.83
EPS
N/A
0.89
Revenue
$65,324,000.00
$96,252,000.00
Revenue This Year
$0.99
$10.97
Revenue Next Year
$0.19
$8.59
P/E Ratio
N/A
$18.98
Revenue Growth
N/A
26.04
52 Week Low
$4.09
$10.88
52 Week High
$15.34
$16.99

Technical Indicators

Market Signals
Indicator
ENTA
PDLB
Relative Strength Index (RSI) 67.09 70.16
Support Level $13.75 $15.65
Resistance Level $14.79 $16.09
Average True Range (ATR) 0.74 0.35
MACD -0.01 0.10
Stochastic Oscillator 90.89 99.72

Price Performance

Historical Comparison
ENTA
PDLB

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: